Comparing rosiglitazone with ethinylestradiol/cyproterone acetate in the treatment of polycystic ovary syndrome

By Pesant Marie-Hélène   Baillargeon Jean-Patrice  

Expert Review of Obstretrics and Gynecology, Vol. 1, Iss. 1, 2006-09 ,pp. : 81-92

Informa Healthcare

Access to resources Recommend Favorite

Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism

By Lumachi F.   Rondinone R.  

Fertility and Sterility, Vol. 79, Iss. 4, 2003-04 ,pp. : 942-946

Elsevier

Access to resources Recommend Favorite

Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes

By Villaseca P   Hormaza P   Cárdenas I   Oestreicher E   Arteaga E  

The European Journal of Contraception and Reproductive Health Care, Vol. 9, Iss. 3, 2004-09 ,pp. : 155-165

Informa Healthcare

Access to resources Recommend Favorite

The effects of a 3-month depot preparation of leuprorelin acetate on pain symptoms, bone mineral density and hormone levels in women with endometriosis—preliminary data analysis

By Baxter Niki   Duffy Sean  

Gynecological Surgery, Vol. 1, Iss. 2, 2004-06 ,pp. : 107-109

Springer Publishing Company

Access to resources Recommend Favorite

Cyproterone acetate- and ethinyloestradiol-containing oral contraceptive as a risk factor for upper extremity deep venous thrombosis-a case report

By Kapur Rick   Stramrood Claire   Schutgens Roger   van Asbeck B. Sweder  

The European Journal of Contraception and Reproductive Health Care, Vol. 14, Iss. 2, 2009-04 ,pp. : 160-163

Informa Healthcare

Access to resources Recommend Favorite